Analysts at The Goldman Sachs Group assumed coverage on shares of Coty (NYSE:COTY – Get Free Report) in a research report issued to clients and investors on Friday, MarketBeat.com reports. The brokerage set a “neutral” rating and a $9.00 price target on the stock. The Goldman Sachs Group’s price objective suggests a potential upside of 20.00% from the company’s previous close.
Several other analysts also recently issued reports on the stock. Citigroup cut their target price on shares of Coty from $10.50 to $10.00 and set a “neutral” rating on the stock in a research note on Monday, October 14th. Wells Fargo & Company dropped their price target on Coty from $10.00 to $9.00 and set an “equal weight” rating on the stock in a research report on Tuesday, October 15th. TD Cowen lowered Coty from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $11.00 to $8.50 in a research report on Wednesday, November 13th. Evercore ISI reiterated an “outperform” rating and issued a $15.00 target price on shares of Coty in a report on Wednesday, August 21st. Finally, Canaccord Genuity Group restated a “buy” rating and set a $14.00 price target on shares of Coty in a report on Tuesday, October 15th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $11.41.
Check Out Our Latest Stock Analysis on Coty
Coty Trading Up 0.4 %
Coty (NYSE:COTY – Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $0.15 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.04). Coty had a return on equity of 9.16% and a net margin of 2.78%. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same quarter in the previous year, the business earned $0.09 earnings per share. The business’s quarterly revenue was up 1.8% compared to the same quarter last year. Sell-side analysts forecast that Coty will post 0.51 earnings per share for the current year.
Institutional Trading of Coty
A number of institutional investors and hedge funds have recently made changes to their positions in COTY. Blue Trust Inc. increased its holdings in shares of Coty by 330.3% during the 3rd quarter. Blue Trust Inc. now owns 3,107 shares of the company’s stock valued at $31,000 after acquiring an additional 2,385 shares during the last quarter. Virtu Financial LLC bought a new stake in Coty during the third quarter worth approximately $96,000. WealthShield Partners LLC acquired a new position in Coty during the second quarter valued at approximately $100,000. Fifth Third Wealth Advisors LLC bought a new position in shares of Coty in the second quarter valued at approximately $107,000. Finally, Capstone Investment Advisors LLC acquired a new stake in shares of Coty in the third quarter worth $109,000. Institutional investors and hedge funds own 42.36% of the company’s stock.
Coty Company Profile
Coty Inc, together with its subsidiaries, manufactures, markets, distributes, and sells beauty products worldwide. It operates through Prestige and Consumer Beauty segments. The company provides fragrance, color cosmetics, and skin and body care products. It offers Prestige segment products primarily through prestige retailers, including perfumeries, department stores, e-retailers, direct-to-consumer websites, and duty-free shops under the Burberry, Calvin Klein, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Joop!, Kylie Jenner, Lancaster, Marc Jacobs, Miu Miu, Orveda, philosophy, SKKN BY KIM, and Tiffany & Co brands.
See Also
- Five stocks we like better than Coty
- What Are Trending Stocks? Trending Stocks Explained
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Business Services Stocks Investing
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is the Shanghai Stock Exchange Composite Index?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Coty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coty and related companies with MarketBeat.com's FREE daily email newsletter.